Share this NATF page   

Dr. Goldhaber

August President's Letter

NATF completed this year a pivotal project, the Atrial Fibrillation Action Initiative.  Led by Board Member Christian T. Ruff, MD, MPH, the Atrial Fibrillation Action Initiative serves the patient and healthcare provider communities with updated and factual information on how best to prevent stroke from atrial fibrillation (AF)... (read more)

Announcements and Updates

PRELIMINARY PROGRAM

HEPARIN CENTENNIAL SYMPOSIUM

Scientific and Clinical Developments and their Impact on the Understanding of the Pathogenesis of Thrombosis and its Management

Loyala University Medical Center

Auditorium CTRE Building

October 28, 2016

Under the Auspices of International Union of Angiology and The North American Thrombosis Forum

 logo hep

HEPARIN CENTENNIAL SYMPOSIUM

A Century of Scientific Fascination and Clinical Implementation

In conjunction with XXVII World Congress of the International Union of Angiology and 15th Congress of the

French Society of Vascular Medicine

Lyon, France

Friday, October 7, 2016

 

CME milo

NOVEL MECHANISMS AND ADVANCING THERAPEUTIC PARADIGMS FOR OPTIMIZING REAL WORLD MANAGEMENT OF THE HYPERCHOLESTEROLEMIA

Free CME Summit

Saturday, September 17, 2016

Boston Marriott Long Wharf

A distinguished panel of national cardiovascular medicine experts, including Harvard’s Deepak Bhatt, MD and Paul Ridker, MD, will discuss practical, patient-centric approaches to LDL lowering, with a focus on the case-based application of multimodal approaches  to LDL management across the hypercholesterolemic morbidity continuum, including diabetes, statin intolerance, and poorly responsive patients with elevated LDL.

Register Now

Upcoming Events

sumsmall

2016 THROMBOSIS SUMMIT
Saturday, October 1
7:00 AM - 12:00 PM
Fairmont Copley Plaza Hotel, Boston, MA

This special half-day program is designed for physicians, pharmacists, nurses, nurse practitioners, physician assistants,and allied health professionals.  Patients, family members and caregivers are also encouraged to attend.

Earn up to 3.5 CME credits for attendance

Experts in the field of Thrombosis Medicine will share updates from breakthrough research that has been completed over the last year on blood clots including heart attack, stroke as a result of atrial fibrillation, pulmonary embolism, and deep vein thrombosis. 

Three patient survivors of major thrombotic events will provide their perspective, recounting their experience from initial symptoms and diagnosis through treatment to recovery. Reserve your seat now!

Learn More

Register Now

The date of the Summit meeting is scheduled to coincide with the

DAWN logo

10th ANNUAL NORTH AMERICAN DAWN AC USER GROUP

Friday, September 30
Brigham and Women'
s Hospital

View Agenda

To register or find out more
about the program, please contact
Melissa Blanchard at Melissa@4s-dawn.com

banner bootcamp

Space Still Available!

5th Regional AC Forum Bootcamp

Albuquerque, NM

October 6-7, 2016

Hotel Albuquerque at Old Town

Registration $399

This compact 2-day meeting provides a comprehensive curriculum that covers the essential aspects of anticoagulation,disease state, and drug management.  Engaging discussion around quality improvement, new agents and special situations will benefit all practicioners and daily "chalk talks" will allow for attendee participation to shape the topics.

For more information or to register visit
www.acforumbootcamp.org


 

 

Thrombosis Education

IMG_5730

DVT/PE TREATMENT OPTIONS

How do healthcare providers decide which treatments are the best option for their patients?  Read this article to find out more about DVT/PE treatment goals, options, risks, and decision-making.  

 

Anticoagulant Comparison Chart

WHICH ANTICOAGULANT IS RIGHT FOR ME?

For many years, Warfarin was the only oral anticoagulant commonly used to treat blood clots. In the past five years, the FDA has approved four new oral anticoagulants for the treatment of DVT, PE, and SPAF. Find out the differences between the five FDA-approved oral anticoagulants. View the Chart.

 

ATRIAL FIBRILLATION ACTION INITIATIVE - NOW PUBLISHED

The American Journal of Medicine published the NATF Atrial Fibrillation Action Initiative consensus document in April 2016.  This document presents usable recommendations on stroke prevention, bleeding risk assessment, and anticoagulation management based off clinical trial data and guideline updates for Afib. Please visit the AFib section of our website to learn more.

 

AHS


 

About NATF

Patients

Professionals

Events


Membership

Giving to NATF

North American Thrombosis Forum
368 Boylston Street
Brookline, MA 02445

617 - 730 - 4120


NATF is a 501(c) nonprofit

Contact Us

© 2012 North American Thrombosis Forum


Web Development by MTC